Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst Holler

Showing results (81-90 of 265) with videos related to

Pageof 27
Sort By:
Journal of Leukocyte Biology|November 13, 2003
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathwaySilvia Kirchner, Simone Boldt, Walter Kolch, et al.
Haematologica|September 24, 2016
Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationChristina Hart, Sabine Klatt, Johann Barop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 10, 2010
Diagnosis and staging of chronic graft-versus-host disease in the clinical practiceHildegard T Greinix, Christoph Loddenkemper, Steven Z Pavletic, et al.
Immunology|July 14, 2005
Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cellsNalini K Vudattu, Ernst Holler, Patricia Ewing, et al.
Experimental Hematology|January 3, 2007
Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host diseasePatricia Ewing, Sandra Miklos, Krystyna M Olkiewicz, et al.
Blood|April 20, 2004
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantationErnst Holler, Gerhard Rogler, Hans Herfarth, et al.
Cell Transplantation|September 14, 2017
Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow TransplantationPeter M Schmid, Abdellatif Bouazzaoui, Karin Schmid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantationArmin Gerbitz, Patricia Ewing, Andrea Wilke, et al.
Perfusion|July 5, 2006
Direct evidence of endothelial injury during cardiopulmonary bypass by demonstration of circulating endothelial cellsFranz-Xaver Schmid, Bernhard Floerchinger, Nalini Kumar Vudattu, et al.
Annals of Hematology|February 23, 2020
IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysisAnna-Sophia Kattner, Ernst Holler, Barbara Holler, et al.
Pageof 27

Showing results (81-90 of 265) with videos related to

Sort By:
Pageof 27
Journal of Leukocyte Biology|November 13, 2003
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathwaySilvia Kirchner, Simone Boldt, Walter Kolch, et al.
Haematologica|September 24, 2016
Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantationChristina Hart, Sabine Klatt, Johann Barop, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 10, 2010
Diagnosis and staging of chronic graft-versus-host disease in the clinical practiceHildegard T Greinix, Christoph Loddenkemper, Steven Z Pavletic, et al.
Immunology|July 14, 2005
Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cellsNalini K Vudattu, Ernst Holler, Patricia Ewing, et al.
Experimental Hematology|January 3, 2007
Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host diseasePatricia Ewing, Sandra Miklos, Krystyna M Olkiewicz, et al.
Blood|April 20, 2004
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantationErnst Holler, Gerhard Rogler, Hans Herfarth, et al.
Cell Transplantation|September 14, 2017
Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow TransplantationPeter M Schmid, Abdellatif Bouazzaoui, Karin Schmid, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantationArmin Gerbitz, Patricia Ewing, Andrea Wilke, et al.
Perfusion|July 5, 2006
Direct evidence of endothelial injury during cardiopulmonary bypass by demonstration of circulating endothelial cellsFranz-Xaver Schmid, Bernhard Floerchinger, Nalini Kumar Vudattu, et al.
Annals of Hematology|February 23, 2020
IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysisAnna-Sophia Kattner, Ernst Holler, Barbara Holler, et al.
Pageof 27